SIGNIFICANT MARKET OPPORTUNITIES
High demand for sustainable products that can compete with conventional products on ease-of-use, efficacy, safety, cost and reliability.
-
Ongoing pressure on the conventional pesticides market, which is subject to increased scrutiny and regulatory pressures contributing to significant disruption.
-
Increasing time and cost of bringing new conventional chemical products to market: 10-12 years and around $300 million.
-
Significantly lower costs of bringing biopesticides to market – around $25 million.
-
Major product withdrawals across all segments of the conventional crop protection industry are having a significant impact on growers leaving them with lower yields and declining productivity.
UNIQUE TECHNOLOGY
Sustaine® encapsulation technology is free from plastics/polymers and facilitates phased release over multiple hydration events.
-
Ownership of the patents behind the Sustaine encapsulation technology.
-
Proven efficacy with strong commercial validation by farmers and our partners.
-
Scope to exploit the core technologies beyond existing markets and products.
-
Eden’s products serve as sustainable alternatives to conventional chemicals without limitations such as residue limits, pest resistance, long pre-harvest intervals and field re-entry periods or increasing restrictions on use such as the proposed microplastics legislation.
-
Residue-free crops command a higher value and have a significant commercial advantage in the valuable export markets.
CLEAR COMMERCIAL PROGRESS
Product sales continue to progress well with expansion into new markets.
-
Solid commercial pipeline.
-
Regulatory clearance for product sales across multiple countries with applications pending in a number of countries.
-
Commercial and collaborative relationships with strong industry partners.
-
Significant investment in commercialisation by key partners.
-
Applications on key crops increasing with further approvals and label extensions.
-
Sales on four continents today – expected to expand to six in the coming years.
SKILLED AND EXPERIENCED PROFESSIONALS
Building on a core team with significant industrial experience.
-
Strong Board and management team.
-
Lykele van der Broek appointed as Non-Executive Director and Chairman – former Board member and COO of Bayer CropScience.
-
Wealth of experience in the agriculture, consumer products and animal health sectors globally.
-
In-house expertise in formulation chemistry and biology.
-
Outsourcing of some functions to maintain a flexible, low overheard base.
TRAJECTORY OF FINANCIAL GROWTH
Continuous development of sales territories and distributor relationships.
|
Revenue
£3.2m
(2022: £1.8m)
|
Product sales
£2.6m
(2022: £1.6m)
|
|
Opertating loss
£1.9m
(2022: £2.6m)
|
Cash at bank
£7.4m
(2022: £2.0m)
|
|